3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
3
Observational
2
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
3
Conditions
Osteosarcoma
3
Neoplasms, Bone Tissue
1
Interventions
Ifosfamide
30
Methotrexate
27
Doxorubicin
25
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
cabozantinib
9
apatinib
9
Specimen Handling
9
Carboplatin
9
fludarabine
8
X-Rays
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Radiotherapy
7
Phantoms, Imaging
7
Biopsy
7
Topotecan
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Osteosarcoma
×
mifamurtide
×
Clear all
NCT03643133
2026-05-19
SARCOME13
UNICANCER
Phase 2
Active not recruiting
60 enrolled
NCT01459484
2024-05-20
ISG/OS-2
Italian Sarcoma Group
Phase 2
Completed
225 enrolled
NCT02441309
2019-09-13
MEMOS
University of Oxford
Phase 2
Terminated
8 enrolled
17 charts